Systemic AL amyloidosis with acquired factor X deficiency: A study of perioperative bleeding risk and treatment outcomes in 60 patients
Open Access
- 1 December 2009
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 85 (3), 171-173
- https://doi.org/10.1002/ajh.21603
Abstract
Systemic light‐chain (AL) amyloidosis may be associated with acquired factor X (FX) deficiency and optimal management of this coagulopathy is unknown. We reviewed our experience with 60 patients with isolated FX deficiency (≤50%) due to AL amyloidosis that underwent an invasive procedure between 1975 and 2007. They were classified as having severe (n = 6), moderate (10–25%; n = 15), or mild (26–50%; n = 39) FX deficiency. The patients underwent a total of 112 procedures, 19 (17%) of which were managed with periprocedural treatment with one or more hemostatic agents. There were complications in 14 (13%) procedures (bleeding = 12, thrombosis = 1, death = 1). Baseline FX level was not predictive of bleeding risk; the only association with postintervention bleeding was central venous catheter placement. However, bleeding complications were relatively infrequent, particularly in patients with mild or moderate FX deficiency undergoing nonvascular procedures. Activated recombinant factor VII might be considered in patients undergoing major surgical procedures, but further experience is needed. Optimal management of AL patients with FX deficiency undergoing invasive procedures remains to be determined. Am. J. Hematol., 2010.Keywords
This publication has 22 references indexed in Scilit:
- Central venous access devices for paediatric patients with haemophilia: a single‐institution experienceHaemophilia, 2009
- Refractory hematuria from amyloidosis successfully treated by splenectomyUrology, 2006
- Natural history of thromboembolism in AL amyloidosisAmyloid, 2006
- Successful perioperative management of factor X deficiency associated with primary amyloidosisJournal of Gastrointestinal Surgery, 2004
- Presurgical plasma exchange is ineffective in correcting amyloid associated factor X deficiencyJournal of Clinical Apheresis, 2004
- Guidelines on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disordersHaemophilia, 2003
- Factor‐X deficiency in amyloidosis: A critical reviewAmerican Journal of Hematology, 1981
- Mechanism of Factor X Deficiency in Systemic AmyloidosisNew England Journal of Medicine, 1981
- Factor X Deficiency in Primary AmyloidosisNew England Journal of Medicine, 1979
- Syndrome of Acquired Factor X Deficiency and Systemic AmyloidosisNew England Journal of Medicine, 1977